tiprankstipranks
Trending News
More News >
LifeClean International AB (SE:LCLEAN)
:LCLEAN

LifeClean International AB (LCLEAN) AI Stock Analysis

Compare
0 Followers

Top Page

SE:LCLEAN

LifeClean International AB

(LCLEAN)

Select Model
Select Model
Select Model
Neutral 42 (OpenAI - 5.2)
Rating:42Neutral
Price Target:
kr0.06
▼(-38.89% Downside)
Action:ReiteratedDate:02/10/26
The score is driven down primarily by severe financial stress (deep losses, negative gross profit in 2025, persistent cash burn, and a pressured balance sheet). Technicals add further risk given a clear downtrend despite oversold readings. Valuation provides limited support because negative earnings make P/E uninformative and no dividend yield is available.
Positive Factors
Infection-prevention product focus
A clear, specialized focus on hygiene and infection-prevention targets durable end markets (healthcare, public facilities, professional cleaning). Structural demand for infection control supports recurring product and service needs, aiding long-term revenue stability if execution matches market requirements.
Reported reduction in total debt (2025)
Lower reported debt in 2025 versus prior years modestly reduces immediate solvency pressure and lengthens runway versus earlier peaks. This improvement, if sustained, increases financial flexibility to execute restructuring or commercial recovery without immediate refinancing urgency.
Improvement in EBITDA losses versus 2024
An improvement in EBITDA losses indicates operational leverage or cost control progress, which is a durable sign management can stabilize operations. If maintained, this can form the foundation for margin recovery and reduce future cash burn requirements over the coming quarters.
Negative Factors
Persistent negative operating and free cash flow
Consistent negative operating and free cash flow signals the business is burning cash rather than self-funding. Over a multi-quarter horizon this necessitates external financing or asset sales, which can dilute shareholders, increase leverage, or force cutbacks that impede growth and execution.
Negative gross profit in 2025
A negative gross profit means core product economics were unfavorable in 2025; costs exceeded revenue before overhead. This is a structural red flag: without pricing, mix, or cost-of-goods improvements the business model is not sustainable and margin recovery is required to avoid ongoing losses.
High leverage and thin/unstable equity
High leverage and thin or negative equity raise solvency and refinancing risk, limiting the company's ability to absorb shocks or fund growth. Over the medium term this constrains strategic options and increases probability of distress-driven outcomes absent sustained profitability or fresh capital.

LifeClean International AB (LCLEAN) vs. iShares MSCI Sweden ETF (EWD)

LifeClean International AB Business Overview & Revenue Model

Company DescriptionLifeClean International AB (publ) researches, produces, markets, and sells disinfection products in Sweden. It has developed a patented spore, fungal, biofilm, bacterial, and virus-killing surface disinfection for equipment and surfaces, such as floors, walls, furniture, and general roof surfaces. The company was founded in 2012 and is based in Uddevalla, Sweden.
How the Company Makes MoneyLCLEAN generates revenue through several key streams, primarily from the direct sales of its eco-friendly cleaning products to retail and wholesale distributors. The company also engages in business-to-business (B2B) partnerships, supplying products to commercial cleaning services, hotels, and healthcare facilities, which account for a significant portion of its sales. Additionally, LCLEAN has established strategic partnerships with environmental organizations to enhance brand visibility and credibility, further driving sales through co-marketing efforts. The company's online sales platform also contributes to its revenue, allowing direct access to consumers and expanding its market reach. Overall, LCLEAN's revenue model is centered on product sales, strategic partnerships, and a growing e-commerce presence.

LifeClean International AB Financial Statement Overview

Summary
Very weak fundamentals: revenue fell sharply in 2025 (~44% YoY), losses are persistent with extremely negative margins (including negative gross profit in 2025), operating/free cash flow are negative every year (worsening cash burn in 2023–2025), and the balance sheet shows high leverage with a thin/unstable equity cushion (including negative equity in 2024).
Income Statement
18
Very Negative
Revenue has been volatile and recently declined (2025 revenue down ~44% year over year), following modest growth in 2023–2024. Profitability is very weak: net losses persist every year shown, with extremely negative net margins (roughly -65% in 2025 and near -88% in 2024). A key concern is gross profitability deterioration—2025 shows a negative gross profit (and negative gross margin), indicating the core product economics were unfavorable in the latest year despite some improvement in EBITDA losses versus 2024.
Balance Sheet
22
Negative
Leverage is high and balance-sheet strength has deteriorated versus earlier years. Debt is substantial relative to equity, and equity has been thin/unstable (including negative equity in 2024), which raises financing and solvency risk. While total debt came down from 2023–2024 levels into 2025, the company is still operating with very limited equity cushion and deeply negative returns for shareholders in most years shown.
Cash Flow
14
Very Negative
Cash generation is a major weakness: operating cash flow is negative in every year shown, and free cash flow is also consistently negative, worsening sharply in recent years (large outflows in 2023–2025). While free cash flow broadly tracks the net loss (losses converting into cash burn rather than being accounting-only), the continued cash drain implies ongoing reliance on external funding or balance-sheet flexibility to sustain operations.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue54.63M61.15M52.50M47.18M53.36M
Gross Profit-35.33M26.82M22.77M19.52M-30.81M
EBITDA-26.03M-40.87M-32.39M-27.79M-26.05M
Net Income-35.66M-53.72M-44.24M-36.09M-32.75M
Balance Sheet
Total Assets48.10M61.80M68.61M76.37M82.59M
Cash, Cash Equivalents and Short-Term Investments6.88M10.57M8.29M11.61M8.85M
Total Debt27.36M44.90M47.84M32.38M18.54M
Total Liabilities44.73M65.43M67.29M62.56M32.70M
Stockholders Equity3.36M-3.63M1.31M13.81M49.89M
Cash Flow
Free Cash Flow-28.28M-42.66M-39.99M-20.07M-23.01M
Operating Cash Flow-28.23M-40.83M-35.46M-16.96M-21.79M
Investing Cash Flow45.00K-1.85M-4.54M-3.13M-36.51M
Financing Cash Flow24.50M44.96M36.67M22.84M24.68M

LifeClean International AB Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.09
Price Trends
50DMA
0.07
Negative
100DMA
0.10
Negative
200DMA
0.14
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
39.64
Neutral
STOCH
43.86
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:LCLEAN, the sentiment is Negative. The current price of 0.09 is above the 20-day moving average (MA) of 0.05, above the 50-day MA of 0.07, and below the 200-day MA of 0.14, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 39.64 is Neutral, neither overbought nor oversold. The STOCH value of 43.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:LCLEAN.

LifeClean International AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
49
Neutral
kr242.54M-10.79-5.04%2.89%7.92%94.99%
47
Neutral
kr116.31M21.135.40%8.54%-4.76%
44
Neutral
kr31.83M-0.89376.81%97.95%
42
Neutral
kr14.03M-0.20-354.88%-15.74%44.98%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:LCLEAN
LifeClean International AB
0.05
-0.15
-75.12%
SE:QLIFE
Qlife Holding AB
2.03
-0.35
-14.71%
SE:POLYG
Polygiene AB
6.64
-4.53
-40.54%
SE:CLEM
Clemondo Group AB
8.40
1.10
15.07%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 10, 2026